| Lightcalls.com |
|
|
![]() |
At age 56 immediately after undergo...At age 56 immediately after undergoing double bypass surgery George Weber of Portland, Oregon started taking aged garlic extract. Two-and-a half years later, his cholesterol has dropp from a high of 300 to 140 his trigylcerides from 250 to 100 his grave density lipoprotein (LDL) from 200 to 76 Garlic. It's not just for repelling unwanted suitors anymore. notwithstanding that garlic's health-promoting benefits have prolonged been known, an understanding of in what way and why it's good for you is an area popularly undergoing extensive research. And the freshs is promising: Garlic is a powerful antioxidant that can help debar both cancer and heart disease. Despite its health benefits, raw garlic has its downside. It can be irritating to the digestive tract and, after ingestion, leave in its wake an odor to breath and perspiration that not equable a mother can love. For the benefit without the bite, many consumer like Weber, are `opting for garlic postscripts Aged garlic extract (AGE) is unimpaired garlic transformed by an aging proces into a stable, bioavailable addition that's palatable and odorless. Research indicates that AGE can lower cholesterol and life-current pressure. A study at Loma Linda University in California ground that S-allyl cysteine (SAC)--a water-soluble intermix found in garlic--prevented the oxidation of LDL or "bad," cholesterol which, unchecked, can lead to atherosclerosis. Other research, careered at the University of Kentucky community of Pharmacy in Lexington, build that AGE inhibits the synthesis of cholesterol in the liver. At Pennsylvania State University in University Park, researchers originate that that SAC and S-propyl cysteine (SPC)--another combine found in garlic-inhibit the synthesis of triglycerides, elevated flushs of which are linked to heart disease. Aged garlic extract has also been shown to influence a landlord of other ailments, from sickle confined apartment anemia to liver damage--caused by means of excess acetaminophen--to cancer. Researchers at Cornell University construct that certain garlic compounds deactivate carcinogens on preventing damage to DNA, boost immune function, restore normal solitary abode; squalid growth and prevent proliferation of tumor solitary abode; squalids by inhibiting blood supply to cancer cells Garlic was establish in two separate studies to combat cancer in other ways. In united study, garlic blocked testosterone's disease-promoting import on prostate cancer. In another, garlic inhibited solitary abode; squalid changes associated with colon cancer through increasing levels of glutathione--a detoxification enzyme produc naturally in the body John Massoud, 68 of Plano, Texas, was diagnosed with leukemia and told he had alone a few months to live. That was four years ago. After rebounding from intensive chemotherapy--his cancer in remission--he was advised to lower his cholesterol on a levels At his physician's suggestion, Massoud embarked forward a regimen of AGE with lecithin. After six month his cholesterol dropp from 238 to 195 As for Weber, a microbiologist from training, his surgery prompted aggressive changes in his lifestyle. He now dedicates himself to regular exercise and a healthy diet--plus his daily dose of garlic. He attributes his streamlined vital fluid profile in large part to AGE: "I at no time go a day without it." COPYRIGHT 2002 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |